Progress of myeloid-derived suppressor cells in hematological tumors
10.3760/cma.j.cn115356-20200529-00144
- VernacularTitle:骨髓来源抑制性细胞在血液系统肿瘤中的研究进展
- Author:
Yejing ZHU
1
;
Yunliang HAO
;
Yun GUAN
Author Information
1. 济宁医学院临床医学院，山东 济宁 272000
- From:
Journal of Leukemia & Lymphoma
2020;29(11):698-701
- CountryChina
- Language:Chinese
-
Abstract:
Myeloid-derived suppressor cells (MDSC) are a heterogeneous population of immature myeloid cells that can regulate the immune response. They play an important role in the formation and progression of tumors and can suppress immune response in infections and inflammatory diseases. In recent years, MDSC have attracted a lot of attention in the field of tumor immunology, especially in solid tumors, but little is known about the role in hematological tumors. In this paper, the characteristics, functions and related clinical researches of MDSC in hematological tumors including multiple myeloma (MM), lymphoma, leukemia, and myelodysplastic syndrome (MDS) will be summarized to provide new ideas for the treatment of hematologic system tumors.
